Advances in pancreatic islet transplantation in humans
Article first published online: 18 MAR 2005
DOI: 10.1111/j.1463-1326.2005.00476.x
Additional Information
How to Cite
Nanji, S. A. and Shapiro, A. M. J. (2006), Advances in pancreatic islet transplantation in humans. Diabetes, Obesity and Metabolism, 8: 15–25. doi: 10.1111/j.1463-1326.2005.00476.x
Publication History
- Issue published online: 18 MAR 2005
- Article first published online: 18 MAR 2005
- Received 25 January 2004; returned for revision 22 June 2004; revised version accepted 24 November 2004
- Abstract
- Article
- References
- Cited By
Keywords:
- diabetes;
- immunosuppression;
- islet;
- tolerance;
- transplantation
With recent advances in methods of islet isolation and the introduction of more potent and less diabetogenic immunosuppressive therapies, islet transplantation has progressed from research to clinical reality. Presently, several international centres have demonstrated successful clinical outcomes with high rates of insulin independence after islet transplantation. Ongoing refinements in donor pancreas procurement and processing, developments in islet isolation and purification technology, and advances in novel immunological conditioning and induction therapies have led to the acceptance of islet transplantation as a safe and effective therapy for patients with type 1 diabetes. This review provides a historical perspective of islet transplantation, outlines the recent advances and current clinical outcomes, and addresses the present challenges and future directions in clinical islet transplantation.

1463-1326/asset/DOM_centre.gif?v=1&s=16142deadaa0e4eb748c60d6fa67102feb560fc9)
